Cryopyrin-associated periodic syndromes: background and therapeutics

References

• Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005;17:1–14.
   PubMed Web of Science ®Google Scholar
• Inohara N, Nunez G. The NOD: a signaling module that regulates apoptosis and host defense against pathogens. Oncogene. 2001;20:6473–81.
   PubMedGoogle Scholar
• Harton JA, Linhoff MW, Zhang J, Ting JPY. CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J Immunol. 2002;169:4088–93.
   PubMed Web of Science ®Google Scholar
• Jones JDG, Dangl JL. The plant immune system. Nature. 2006;444:323–9.
   PubMed Web of Science ®Google Scholar
• Ting JPY, Lovering RC, Alnemri ES, Bertin J, Boss JM, Davis BK, et al. The NLR gene family: a standard nomenclature. Immunity. 2008;28:285–7.
   PubMed Web of Science ®Google Scholar
• Ye Z, Ting JP-Y. NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr Opin Immunol. 2008;20:3–9.
   Google Scholar
• The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25–31.
   PubMed Web of Science ®Google Scholar
• The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797–807.
   PubMed Web of Science ®Google Scholar
• McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syn-dromes. Cell. 1999;97:133–44.
   PubMed Web of Science ®Google Scholar
• Houten SM, Kuis W, Duran M, de Koning TJ, van Royen-Kerkhof A, Romeijn GJ, et al. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet. 1999;22:175–7.
   Google Scholar
• Drenth JPH, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JGN, et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet. 1999;22:178–81.
   Google Scholar
• Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29:301–5.
   Google Scholar
• Feldmann J, Prieur AM, Quartier P, Berquin P, Certain S, Cortis E, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet. 2002;71:198–203.
   PubMed Web of Science ®Google Scholar
• Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, et al. De novo CIAS1 mutations, cytokine activa-tion, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID). A new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 2002;46:3340–8.
   Google Scholar
• Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouv-rier-Hanu S, Häfner R, et al. CARD15 mutations in Blau syn-drome. Nat Genet. 2001;29: 19–20.
   Google Scholar
• The up-to-date information is available by The Registry of Familial Mediterranean Fever (FMF) and Hereditary Auto-inflammatory Disorders Mutations. http://fmfigh.cnrs.fr/ISSAID/ infevers/.
   Google Scholar
• Proell M, Riedl SJ, Fritz JH, Rojas AM, Schwarzenbacher R. The Nod-like receptor (NLR) family: a tale of similarities and dif-ferences. PLoS ONE. 2008;3:e2119.
   Google Scholar
• Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1/3. Mol Cell. 2002;10: 417–26.
   Google Scholar
• Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR, et al. Association of mutations in the NALP3/CIASI/PY-PAFI gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 2002;46:2445–52.
   PubMed Web of Science ®Google Scholar
• Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1/3-processing inflammsome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20:319–25.
   PubMed Web of Science ®Google Scholar
• Dowds TA, Masumoto J, Zhu L, Inohara N, Näfiez G. Cryopyrin-induced interleukin 1/3 secretion in monocytic cells. Enhanced activity of disease-associated mutants and requirement for ASC. J Biol Chem. 2004;279: 21924–8.
   Google Scholar
• Koike R, Kubota T, Hara Y, Ito S, Suzuki K, Yanagisawa K, et al. A case of Muckle-Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin). Mod Rheumatol. 2007;17:496–9.
   PubMedGoogle Scholar
• Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 2003;11:591–604.
   PubMed Web of Science ®Google Scholar
• Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ. et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1/3 production. Proc Natl Acad Sci USA. 2006;103: 9982–7.
   Google Scholar
• Yu JW, Wu J, Zhang Z, Datta P, Ibrahimi I, Taniguchi S, et al. Cryopyrin and pyrin activate caspase-1, but not NF-KB, via ASC oligomerization. Cell Death Differ. 2006;13:236–49.
   PubMed Web of Science ®Google Scholar
• Seshadri S, Duncan MD, Hart JM, Gavrillin MA, Wewers MD. Pyrin levels in human monocytes and monocyte-derived macro-phages regulate IL-1/3 processing and release. J Immunol. 2007;179: 1274–81.
   Google Scholar
• Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature. 2004;430:213–8.
   PubMed Web of Science ®Google Scholar
• Rosengren S, Hoffman HM, Bugbee W, Boyle DL. Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium. Ann Rheum Dis. 2005;64:708–14.
   PubMed Web of Science ®Google Scholar
• Verma D, Lerm M, Julinder RB, Eriksson P, Sfiderkvist P, Särndahl E. Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflam-mation. Relation to common inflammatory diseases? Arthritis Rheum. 2008;58: 888–94.
   Google Scholar
• Kastbom A, Verma D, Eriksson P, Skogh T, Wingren G, Sfiderkvist P. Genetic variation in proteins of the cryopyrin in-flammasome influences susceptibility and severity of rheumatoid arthritis (The Swedish TIRA project). Rheumatology Oxford. 2008;47:415–7.
   PubMed Web of Science ®Google Scholar
• Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006;440:228–32.
   Google Scholar
• Kanneganti TD, Qzören N, Body-Malapel M, Amer A, Park JH, Franchi L, et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature. 2006; 440:233–6.
   PubMed Web of Science ®Google Scholar
• Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-/3. Nat Immunol. 2008;9: 857–65.
   PubMed Web of Science ®Google Scholar
• Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–41.
   PubMed Web of Science ®Google Scholar
• Hornung V, Bauemfeind F, Halle A, Samstad EO, Kono H, Rock KL, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immu-nol. 2008;9:847–56.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Gaide O, Pétrilli V, Martinon F, Contassot E, Rogues S, et al. Activation of the IL-1/3-processing inflamma-some is involved in contact hypersensitivity. J Invest Dermatol. 2007;127: 1956–63.
   Google Scholar
• Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, Beer HD. Theinflammasome mediates UVB -inducedactivation andsecretion of interleukin-1/3 by keratinocytes. CUIT Biol. 2007; 17:1140–5.
   PubMed Web of Science ®Google Scholar
• Omi T, Kumada M, Kamesaki T, Okuda H, Munkhtulga L, Yanagisawa Y, et al. An intronic variable number of tandem repeat polymorphisms of the cold-induced autoinflammatory syndrome I (CIASI) gene modifies gene expression and is associated with essential hypertension. Eur J Hum Genet. 2006;14:1295–305.
   PubMed Web of Science ®Google Scholar
• Hawkins PN, Lachmann HJ. Interleukin- 1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med. 2003;348:2583–4.
   PubMed Web of Science ®Google Scholar
• Leslie KS, Lachmann HJ, Bruning E, McGrath JA, Bybee A, Gallimore JR, et al. Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease asso-ciated with CIAS-I/NALP3 mutations. Arch Dermatol. 2006;142:1591–7.
   PubMed Web of Science ®Google Scholar
• Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 2004;364:1779–85.
   PubMed Web of Science ®Google Scholar
• Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, et al. Neonatal-onset multisystem inflammatory dis-ease responsive to interleukin-1/3 inhibition. N Engl J Med. 2006;355: 581–92.
   Google Scholar
• Mirault T, Launay D, Cuisset L, Hachulla E, Lambert M, Queyrel V, et al. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis Rheum. 2006;54:1697–700.
   PubMed Web of Science ®Google Scholar
• Gattomo M, Tassi S, Carta S, Delfino L, Ferlito F, Pelagatti MA, et al. Pattern of interleukin-1/3 secretion in response to lipo-polysaccharide and ATP before and after interleukin-1 blockade in patients with CIASI mutations. Arthritis Rheum. 2007;56: 3138–48.
   PubMedGoogle Scholar
• Yamazaki T, Masumoto J, Agematsu K, Sawai N, Kobayashi S, Shigemura T, et al. Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome. Arthritis Rheum. 2008;58:864–8.
   PubMedGoogle Scholar
• Matsubara T, Hasegawa M, Shiraishi M, Hoffman HM, Ichiyama T, Tanaka T, et al. A severe case of chronic infantile neurologic, cutaneous, articular syndrome treated with biologic agents. Arthritis Rheum. 2006;54:2314–20.
   PubMedGoogle Scholar
• Goldbach-Mansky R, Shroff SD, Wilson M, Snyder C, Plehn S, Barham B, et al. A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (Interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum. 2008;58: 2432–42.
   Google Scholar
• Hoffman HM, Throne ML, Amar NJ, Sebai M, Kivitz AJ, Kavanaugh A, et al. Efficacy and safety of rilonacept (Interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes. Results from two sequential placebo-controlled studies. Arthritis Rheum. 2008;58:2443–52.
   PubMed Web of Science ®Google Scholar
• Lachmann HT, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, et al. Use of canakinumab in the cryop-yrin-associated periodic syndrome. N Engl J Med. 2009; 360:2416–25.
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Lowe P, Felix SD, Rordorf C, Leslie K, Madhoo S, et al. In vivo regulation of interleukin 1)1 in patients with cryopyrin-associated periodic syndromes. J Exp Med. 2009; 206:1029–36.
   PubMed Web of Science ®Google Scholar